None
EN
Gilead Sciences says remdesivir-copy patent in UPC action worth €20 million
['Angela Morris', 'View Full Biography']
IAM
Gilead Sciences says remdesivir-copy patent in UPC action worth €20 millionThe purported high-value asset of patentee the Academy of Military Medical Sciences that Gilead challenged in a UPC revocation action could lead to legal cost recovery of up to €1.2 million
['upc'
'worth'
'million'
'revocation'
'sciences'
'20'
'action'
'patentee'
'purported'
'remdesivircopy'
'recovery'
'gilead'
'patent']